NM_001367421.2:c.-85+16647G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001367421.2(GRAMD1B):c.-85+16647G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.461 in 151,912 control chromosomes in the GnomAD database, including 20,916 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.46 ( 20916 hom., cov: 31)
Consequence
GRAMD1B
NM_001367421.2 intron
NM_001367421.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.188
Publications
3 publications found
Genes affected
GRAMD1B (HGNC:29214): (GRAM domain containing 1B) Predicted to enable cholesterol binding activity; cholesterol transfer activity; and phospholipid binding activity. Predicted to be involved in cellular response to cholesterol and cholesterol homeostasis. Located in endoplasmic reticulum membrane; endoplasmic reticulum-plasma membrane contact site; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.857 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRAMD1B | NM_001367421.2 | c.-85+16647G>A | intron_variant | Intron 1 of 20 | NP_001354350.1 | |||
GRAMD1B | NM_001367420.2 | c.26+16647G>A | intron_variant | Intron 1 of 20 | NP_001354349.1 | |||
GRAMD1B | NM_001367419.2 | c.26+16647G>A | intron_variant | Intron 1 of 20 | NP_001354348.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRAMD1B | ENST00000638157.1 | c.-176+16647G>A | intron_variant | Intron 1 of 20 | 5 | ENSP00000489896.1 |
Frequencies
GnomAD3 genomes AF: 0.461 AC: 69927AN: 151794Hom.: 20862 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
69927
AN:
151794
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.461 AC: 70023AN: 151912Hom.: 20916 Cov.: 31 AF XY: 0.451 AC XY: 33487AN XY: 74224 show subpopulations
GnomAD4 genome
AF:
AC:
70023
AN:
151912
Hom.:
Cov.:
31
AF XY:
AC XY:
33487
AN XY:
74224
show subpopulations
African (AFR)
AF:
AC:
35803
AN:
41434
American (AMR)
AF:
AC:
5276
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
1249
AN:
3466
East Asian (EAS)
AF:
AC:
1074
AN:
5158
South Asian (SAS)
AF:
AC:
1208
AN:
4814
European-Finnish (FIN)
AF:
AC:
2852
AN:
10516
Middle Eastern (MID)
AF:
AC:
121
AN:
294
European-Non Finnish (NFE)
AF:
AC:
21173
AN:
67940
Other (OTH)
AF:
AC:
882
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1468
2936
4405
5873
7341
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
988
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.